PregnanTech is a medical device company with the mission of bringing about significant change in women's and pediatric health and reducing the rate of preterm births worldwide.
PregnanTech's vibrant team includes physicians, medical device specialists, clinical and regulatory experts and business advisors.
PregnanTech is a portfolio company of The Trendlines Group.
Dr. David Shashar (MD, Ob/Gyn, MBA, BME)
CEO and Founder
David Shashar received his medical degree from the Hebrew University in Jerusalem and is board certified in obstetrics and gynecology. He holds an executive MBA from the Kellogg-Recanati Business School and a MSc in biomedical engineering from the Technion-Israel Institute of Technology.
Prior to leading PregnanTech, David was the medical director of multidisciplinary collaboration platforms at Sheba Medical Center, assigned to proactively align physicians and engineers from the Israeli medical industry and academia to develop cost-effective, innovative medical technology solutions to meet pressing clinical problems. He has extensive experience in inventing, innovating and developing new medical technologies.
Mr. Steve Rhodes
Mr. Rhodes is the chairman and founder of The Trendlines Group. Steve holds a BA from Harvard University and holds an MBA from the University of Chicago. He has extensive investment experience and serves as a director in many of Trendlines' portfolio companies. Mr. Rhodes has years of management experience, including in-depth understanding of all the financial and organizational requirements for commercial exploitation of start-up companies. Steve has been active in the medical device industry for more than 30 years, first as a senior executive in a medical device company and subsequently as an investor, director, and mentor.
Prof. Eyal Schiff
Formerly the Chairman of the Obstetrics and Gynecology Division at Sheba Medical Center, Tel-Aviv University Israel. Professor Schiff headed Sheba's high-risk obstetrics and prenatal services departments. He has published over 100 academic papers in his field. Prof. Schiff has extensive experience in managing medical organizations with large teams, experience as CEO and COO of technology startup companies, healthy relationships with the VC industry and experience as a director and investor in several other biotech innovative start-up companies in the computational and pharma fields.
Dr. Susan Alpert
Clinical & Regulatory advisor
Susan was most recently the Senior Vice President, Chief Regulatory Officer of Medtronic and was responsible for all Medtronic global regulatory efforts. Before joining Medtronic, Dr. Alpert served as Vice President of Regulatory Sciences for C.R. Bard, Inc.. She previously worked at the FDA where she held a variety of positions in the centers dealing with drugs, devices and radiological health and foods, including six years as the Director of the Office of Device Evaluation. Dr. Alpert is a microbiologist and a pediatrician.